Clinical Trials Browser

Phase NA × Cisplatin × Thoracic × Clear all

NCT02194738 2026-04-13

Genetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)

Phase NA Active not recruiting

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT06484491 2026-01-30

HyDose

Phase NA Recruiting

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT06480864 2025-01-06

Adebrelimab Plus Apatinib for Maintenance Therapy of Extensive Stage Small Cell Lung Cancer

Phase NA Recruiting

Small Cell Lung Carcinoma

NCT03214003 2023-06-22

TRISS

Phase NA Completed

Small Cell Lung Cancer Limited Stage

NCT00883480 2022-06-13

SLAT

Phase NA Completed

Carcinoma, Non-Small-Cell Lung

NCT04731909 2021-02-10

Toripalimab Combined With Anlotinib, Etoposide and Platinum in the Treatment of Extensive-stage Small Cell Lung Cancer

Phase NA Unknown

Lung Neoplasms, Small Cell Lung Carcinoma

NCT03671538 2018-09-17

Non Squamous NSCLC Patients With Anlotinib Combined With Pemetrexed and Cisplatin

Phase NA Unknown

Non-squamous Non-small Cell Lung Cancer

NCT03413358 2018-01-29

Clinical Trial for Post-marketing Evaluation of Sheng Bai Oral Liquid

Phase NA Unknown

Carcinoma, Non-Small-Cell Lung

NCT02407912 2015-11-20

Cisplatin for Malignant Pleural Effusion in Patients With Non-small-cell Lung Cancer

Phase NA Unknown

Pleural Effusion, Malignant

NCT02549261 2015-09-15

Nimotuzumab in Combination With Radiochemotherapy for Patients With Stage IIIA/IIIB Non-small Cell Lung Cancer

Phase NA Unknown

Carcinoma, Non-Small-Cell Lung

NCT01209520 2015-02-24

Residual Hypermethylation in Early Stage Non-Small Cell Lung Cancer (NSCLC) As Part of Adjuvant Therapy and Preventive Strategy

Phase NA Completed

6 enrolled 6 charts

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Carcinogenesis